依西美坦|来曲唑、阿那曲唑、依西美坦,乳腺癌内分泌治疗咋选择?( 二 )


1、De Placido S, Gallo C, De Laurentiis M, et al. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial. Lancet Oncol 2018; 19:474.
2、Campos SM, Guastalla JP, Subar M, et al. A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases. Clin Breast Cancer 2009; 9:39.
【依西美坦|来曲唑、阿那曲唑、依西美坦,乳腺癌内分泌治疗咋选择?】3、Chen S, Lan B, Lv D, et al. Bone safety profile of steroidal aromatase inhibitor in comparison to non-steroidal aromatase inhibitors in postmenopausal women with breast cancer: A network meta-analysis[J]. 2021.

推荐阅读